Targeted Luminescent Probes for Precise Upconversion/NIR II Luminescence Diagnosis of Lung Adenocarcinoma
Ruichan Lv,Yanxing Wang,Bi Lin,Xiangrong Peng,Jun Liu,Wei-dong Lü,Jie Tian,Ruichan Lv,Yanxing Wang,Bi Lin,Xiangrong Peng,Jun Liu,Wei-dong Lü,Jie Tian
DOI: https://doi.org/10.1021/acs.analchem.1c00374
IF: 7.4
2021-03-11
Analytical Chemistry
Abstract:In this research, the antibody of the searched hub genes has been proposed to combine with a rare-earth composite for an upconversion luminescence (UCL) and downconversion (DCL) NIR-II imaging strategy for the diagnosis of lung adenocarcinoma (LUAD). Weighted gene co-expression network analysis is used to search the most relevant hub genes, and the required top genes that contribute to tumorigenesis (negative: CLEC3B, MFAP4, PECAM1, and FHL1; positive: CCNB2, CDCA5, HMMR, and TOP2A) are identified and validated by survival analysis and transcriptional and translational results. Meanwhile, fluorescence imaging probes (NaYF<sub>4</sub>:Yb,Er,<sub>4</sub>:Nd, denoted as NYF:Eu NPs) with multimodal optical imaging properties of downconversion and upconversion luminescence in the visible region and luminescence in the near infrared II region are designed with various uniform sizes and enhanced penetration and sensitivity. Finally, when the NYF:Eu NP probe is combined with antibodies of these chosen positive hub genes (such as, TOP2A and CCNB2), the <i>in vitro</i> and <i>in vivo</i> animal experiments (flow cytometry, cell counting kit-8 assay using A549 cells, and <i>in vivo</i> immunohistochemistry IHC microscopy images of LUAD from patient cases) indicate that the designed nanoprobes can be excellently used as a targeted optical probe for future accurate diagnosis and surgery navigation of LUAD in contrast with other cancer cells and normal cells. This strategy of antibodies combined with optical probes provides a dual-modal luminescence imaging method for precise medicine.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.analchem.1c00374?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.analchem.1c00374</a>.Average expression level of each sample in the GSE32863 data set and the sample clustering map; hierarchical clustering heat map of normal samples and LUAD; volcano map of DEGs; sample clustering and determination of soft threshold strength; construction of WGCNA and identification of key modules; sample clustering of soft threshold strength; co-expression module using a cluster tree of characteristic genes; gene cluster dendrogram; network heatmap plot of co-expressed genes; module clustering dendrogram of the center gene; heatmap network of adjacent center genes; survival analysis of the hub genes in GEPIA and in kmplot; hub genes verified in TCGA-LUAD; hub genes verified at the transcriptional level; hub genes verified at the transcriptional level using other TCGA data sets in DAVID; genetic alterations associated with the hub gene in TCGA-LUAD; UCL and NIR II luminescence spectra of the Yb,Er, and Yb,Er, core/shell nanocrystals with different Ce and Eu doping concentrations; luminescence intensity versus pump power of Yb,, Yb,Er,, and Yb,Er, (Ex: 808 nm; Em: 1550 nm); NIR-II imaging of the Yb,Er, core/shell nanocrsytals under a thick breast chicken tissue; excitation and emission spectra of Yb,Er,Ce nanoparticles; CLSM images of A549 cells incubated with NYF:Eu-CCNB2 and NYF:Eu-TOP2A (with DIO and mito-tracker marked); CLSM images of cells incubated with pure NYF:Eu and NYF:Eu-CCNB2 material (with only mito-tracker marked); CLSM images of cells incubated with NYF:Eu, NYF:Eu-CCNB2, and NYF:Eu-TOP2A for different time points; calculation of the signal/noise ratio; <i>in vivo</i> NIR II fluorescence image of the mouse grown with 4T1 and A549 tumor cells with NYF:Eu-TOP2A and NYF:Eu-CCNB2; <i>in vivo</i> fluorescence imaging photograph of the mouse grown with 4T1 and A549 tumor cells intravenously injected by NYF:Eu-TOP2A for different time points: 0.5–24 h; photographs and images with different patient cases; biostability of nanoprobes in different biophysical solutions; microscopy photographs (luminescence and bright field) of the sliced organs of heart, intestines, kidney, liver, lung, and spleen of the mice injected with NYF:Eu intravenously, and corresponding luminescence intensity in different organs; NIR II and IVIS imaging photographs of the mice and corresponding quantitative analysis of NYF:Eu-CCNB2 and NYF:Eu-TOP2A injected by the tail vein (<a class="ext-link" href="/doi/suppl/10.1021/acs.analchem.1c00374/suppl_file/ac1c00374_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.
chemistry, analytical